Arkolith/Insider Trading/SBFM/Form 4

Slilaty Steve N.

Chief Executive Officer, Director, 10% OwnerSunshine Biopharma, Inc (SBFM) · full profile →Form 4 · filed Feb 12, 2024
Net Buying
Open-Market Buys
$2K
Open-Market Sells
$0
Net Open-Market Flow
$2K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 8, 2024Buy(P)20K$0.10$2K30K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001683168-24-000879) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML